SaaS HealthTech MiyaHealth Concludes S$10.4M Pre-Series A Fundraise, Sets Sights on Global Expansion
Monday, September 04, 2023
MiyaHealth, a Singapore-headquartered global-first SaaS HealthTech, has closed S$2.4 million Pre-Series A extension round amidst the funding winter, bringing the total fundraise to S$10.4 million. Investors who participated include Fondation Botnar, represented by Sagana, an impact investment advisory firm focused on human and planetary health, together with existing investors ST Engineering Ventures, Elev8, and HealthXCapital, amidst final discussions with other investors. This extension follows the Pre-Series A fundraise of S$6.5 million and S$1.5 million in February and August 2022 respectively, the former being one of the largest Pre-Series A rounds by a HealthTech start-up in Southeast Asia.
The funds will be used to double down on MiyaHealth’s aggressive growth strategy as it looks to expand its AI-driven interoperable digital healthcare solutions across Europe and Southeast Asia, starting with Poland, Indonesia, and the Philippines. By the end of 2023, it plans to onboard more partners, including insurers, hospitals, and governments, to tailor solutions that will scale up healthcare access and efficiency in these countries, as well as future markets of interest such as Thailand, Vietnam, and the Middle East. MiyaHealth will also be expanding its leadership team with strategic hires adept in commercial strategy and client servicing.
“Despite the funding winter that is happening across Southeast Asia, we are heartened to have the support of our new and existing investors. Their investment is a recognition of the value that our digital infrastructure and solutions bring in enabling healthcare systems to scale,” said Dr Ramesh Rajentheran, CEO and Co-Founder of MiyaHealth. “We believe that working together with players across the value chain is vital in tackling healthcare fragmentation. With our new hire, Kevin Yeap, spearheading commercial and customer success, we are confident that we can continue to create value for our partners as well as patients.”
In the last year, MiyaHealth has launched into significant partnerships, including with Bioton in Poland, to create a diabetes management platform adapted from MiyaHealth’s proprietary product, MiyaPatient and its AI-driven avatar MiyaAvatar, to help doctors manage patients remotely. It is currently in its pilot phase in collaboration with academic centres across Poland and will be rolled out later this year. MiyaHealth is also in the final stages of closing multiple 10-year contract deals for MiyaPayor and MiyaProvider in the Philippines and Indonesia.
To support MiyaHealth’s growing footprint, the company has strengthened its leadership bench with a new hire, Kevin Yeap, Head of Commercial and Customer Success. He brings in around 13 years of experience in international expansion and business development and is responsible for pushing growth and value-creation opportunities for MiyaHealth’s partners within the healthcare ecosystem. Prior to this, he held a series of leadership roles in the startup ecosystem, including with EVYD Technology, where he spearheaded accounts development and transformation in Singapore, Brunei, and the United States. He also led business development for IBM Watson Health.
“Our investment in MiyaHealth demonstrates our commitment in using technology to create impactful solutions. Their endeavours in developing SaaS solutions that digitise and automate processes will reduce administration time and costs for hospitals, insurers, and governments. This aligns with our goal of solving real-world problems and improving lives by making healthcare more affordable, ultimately benefiting patients,” said Low Jin Phang, President of Digital Systems at ST Engineering.
"Building a habit of preventative and timely medical care is important for the young population to predict, diagnose, and treat conditions on time. To facilitate this, their interactions with healthcare systems including payors and providers need to be patient-friendly, affordable, accessible and accurate. We are investing in MiyaHealth because the company is focused on building a robust digital healthcare infrastructure that facilitates seamless interaction between patients, providers and payors. For example, Miya Patient empowers young patients by giving them the tools to make informed decisions about their care, including what care to seek, where to seek it, and how much to claim for it. This can lead to significantly improved health outcomes for the region's young, digitally-savvy population," said Sushant Sharma, Chief Investment Officer at Fondation Botnar.
The funding winter that is sweeping through the startup landscape across Southeast Asia and globally has not deterred MiyaHealth’s momentum, as it successfully closes its Pre-Series A fundraise. With a vision to be global from day one, the company hopes to raise Series A in Q1 2024 and to continue to develop its product offerings and technological capabilities, expand its operations and partnerships, as well as strengthen its leadership team to scale up global health systems to serve the needs of patients.
About MiyaHealth
Founded in 2019, MiyaHealth builds and operates digital infrastructure that powers healthcare. The company offers three product suites, namely MiyaPayor, MiyaPatient, and MiyaProvider, all of which leverage MiyaHealth’s AI and ML data capture, processing, and interoperability capabilities across the healthcare ecosystem. MiyaHealth’s technologies enable Payors and Providers to do more with less, and offer patients a better healthcare experience.
For more information, please visit http://www.miyahealth.com/
About ST Engineering Ventures
Established in 2017, Singapore Technologies Engineering Ventures (STEV) is the corporate venture capital unit of Singapore Technologies Engineering Ltd, a global technology, defense and engineering group with offices across Asia, Europe, the Middle East and the U.S., serving customers in more than 100 countries. With offices in Singapore, San Francisco, U.S., and Tel Aviv, Israel, STEV scouts for and invests in promising technology start-ups in high growth areas such as robotics, autonomous technology, data analytics, cybersecurity, IoT, Cloud, Connectivity and other emerging technologies. It aims to build successful, collaborative relationships with start-ups, combining technologies and expertise to co-create breakthrough solutions while enabling their access to the Group’s global business ecosystems, expertise and resources.
About Elev8
Elev8 VC is a B2B focused Deep Tech Venture Capital fund based in Singapore. We focus on early staged investments across 4 key sectors: Smart Mobility, MedTech, Complex Computing, and Novel Materials and Engineering.
About HealthXCapital
HealthXCapital, is the one of the first early-stage healthcare dedicated VCs investing in South and Southeast Asia. HealthXCapital has put together an ecosystem of strategic investors to create a smart connected capital platform for healthtech startups in the region. This ecosystem focuses on clinical validation and accelerated commercialization of startups leveraging its strategic network. HealthXCapital is backed by marquee institutions and partners such as Apollo Hospitals, Jungle Ventures, Eight Road Ventures, Infocom (Japan) and Enterprise Singapore amongst others.
About Central Capital Ventura
Established in 2017, Central Capital Ventura (CCV) is the venture capital arm of Bank Central Asia (BCA), the largest private bank in Indonesia. CCV invests in early stage fintech and embedded finance startups. We leverage our strong financial ecosystem to synergize with our portfolio companies to spur innovation.
About Fondation Botnar
Fondation Botnar is a Swiss philanthropic foundation working to improve the health and wellbeing of young people living in cities around the world. Advocating for the inclusion of youth voices and the equitable use of AI and digital technology, the foundation invests in and supports innovative programs and research, and brings together actors from across sectors to create dialogue and partnerships.
About Sagana
Sagana is an impact investment advisory firm focused on unleashing the potential of business, capital and people to improve human and planetary health.
Source: miyahealth.com